Product Information
CILOXAN 0.3% OINTMENT is a brand product labeled by Sandoz Inc., priced at $74.3121 per GM under NDC 66758007138. Its NADAC has been published 70 times since Jun 4, 2025.
FDA first approved this application on Mar 30, 1998.
The High Outlier badge above means this manufacturer's average price in the ciprofloxacin hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3 mg/g
Manufacturer
Sandoz Inc.NDC
66758007138
Classification
Brand
Dosage Form
OINTMENT
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020369FDA Approved
3/30/1998
On Market Since
6/2/1998
Pharmacological Classes
Price Statistics
The NADAC for CILOXAN 0.3% OINTMENT has been published 70 times since Jun 4, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $74.3121 per GM |
|---|---|
| All-time high | $74.4341 (Nov 12, 2025) |
| All-time low | $74.1988 (Nov 19, 2025) |
| 52-week high | $74.4341 |
| 52-week low | $74.1988 |
| Median price | $74.3471 |
| Average price | $74.3327 |
| Largest weekly change | -0.3% (Nov 19, 2025) |
| Weeks tracked | 70 |
| Tracking since | Jun 4, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ciprofloxacin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ciprofloxacin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Fluoroquinolone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CILOXAN 0.3% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for CILOXAN 0.3% OINTMENT, manufactured by Sandoz Inc., is $74.3121 per GM (NDC 66758007138), effective Sep 30, 2026.
How has the price of CILOXAN 0.3% OINTMENT changed over time?
Over the history we have for it, the NADAC for CILOXAN 0.3% OINTMENT has held within roughly two percent of its current level. It has been tracked across 70 weekly CMS publications since Jun 4, 2025.
What are the highest and lowest recorded NADAC prices for CILOXAN 0.3% OINTMENT?
Since Jun 4, 2025, the NADAC for CILOXAN 0.3% OINTMENT has ranged from a low of $74.1988 (Nov 19, 2025) to a high of $74.4341 (Nov 12, 2025), with a median of $74.3471 per GM.
Are there cheaper alternatives to CILOXAN 0.3% OINTMENT?
No other NADAC-published product currently shares the active ingredient and strength of CILOXAN 0.3% OINTMENT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CILOXAN 0.3% OINTMENT?
CILOXAN 0.3% OINTMENT (NDC 66758007138) is labeled by Sandoz Inc., and CMS classifies it as a brand product.